Abbott Laboratories has surpassed Wall Street estimates for quarterly profit, buoyed by robust sales of its medical devices, particularly glucose-monitoring products. The
Abbott Laboratories has surpassed Wall Street estimates for quarterly profit, buoyed by robust sales of its medical devices, particularly glucose-monitoring products. The